Hyundai Pharmaceutical Co (XKRX:004310) Total Liabilities : ₩72,868 Mil (As of Feb. 2024)

View and export this data going back to 1978. Start your Free Trial

What is Hyundai Pharmaceutical Co Total Liabilities?

Hyundai Pharmaceutical Co's Total Liabilities for the quarter that ended in Feb. 2024 was ₩72,868 Mil.

Hyundai Pharmaceutical Co's quarterly Total Liabilities declined from Aug. 2023 (₩73,155.74 Mil) to Nov. 2023 (₩69,967.63 Mil) but then increased from Nov. 2023 (₩69,967.63 Mil) to Feb. 2024 (₩72,868.19 Mil).

Hyundai Pharmaceutical Co's annual Total Liabilities increased from Nov. 2021 (₩77,257.09 Mil) to Nov. 2022 (₩94,604.15 Mil) but then declined from Nov. 2022 (₩94,604.15 Mil) to Nov. 2023 (₩69,967.63 Mil).

Hyundai Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Hyundai Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyundai Pharmaceutical Co Total Liabilities Chart

Hyundai Pharmaceutical Co Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Total Liabilities

Get a 7-Day Free Trial

62,990.58

67,361.03

77,257.09

94,604.15

69,967.63

Hyundai Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Liabilities	Get a 7-Day Free Trial															93,038.13	76,694.66	73,155.74	69,967.63	72,868.19

Hyundai Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hyundai Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Nov. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	65334.228	+	(580.646	+	1241.438
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2811.32)
	=	69,968

Total Liabilities	=	Total Assets (A: Nov. 2023 )	-	Total Equity (A: Nov. 2023 )
	=	154629.1	-	84661.468
	=	69,968

Hyundai Pharmaceutical Co's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	67871.564	+	(534.095	+	1254.617
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3207.918)
	=	72,868

Total Liabilities	=	Total Assets (Q: Feb. 2024 )	-	Total Equity (Q: Feb. 2024 )
	=	156788.453	-	83920.26
	=	72,868

Hyundai Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co (XKRX:004310) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hyundai Pharmaceutical Co Ltd (XKRX:004310) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Bonegeunsa Street 135, Hyundai Pharm Building, Gangnam-gu, Seoul, KOR, 135-545

Website

http://www.hyundaipharm.co.kr

Hyundai Pharmaceutical Co Ltd is a South Korea based company engage in the manufacturing and distribution of pharmaceutical products, health foods, and medical equipment.

Hyundai Pharmaceutical Co (XKRX:004310) Headlines

No Headlines